Evidence map›Paper›PMID 37346047›Full record

ArticleFrontiers in immunology2023

Large-scale antibody immune response mapping of splenic B cells and bone marrow plasma cells in a transgenic mouse model.

Xiaoli Pan, Sheila N López Acevedo, Camille Cuziol, Evelyn De Tavernier, Ahmed S Fahad, Priyobarta S Longjam, Sambasiva P Rao, David Aguilera-Rodríguez, Mathilde Rezé, Christine A Bricault and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Optimized single-cell gates for yeast display screening.Protein engineering, design & selection : PEDS · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Xiaoli PanDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, United States.
Sheila N López AcevedoDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, United States.
Camille CuziolLarge Molecule Research, Sanofi, Vitry sur Seine, France.
Evelyn De TavernierLarge Molecule Research, Sanofi, Ghent, Belgium.
Ahmed S FahadRagon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard, Cambridge, MA, United States.
Priyobarta S LongjamLarge Molecule Research, Sanofi, Cambridge, MA, United States.
Sambasiva P RaoLarge Molecule Research, Sanofi, Cambridge, MA, United States.
David Aguilera-RodríguezLarge Molecule Research, Sanofi, Ghent, Belgium.
Mathilde RezéLarge Molecule Research, Sanofi, Vitry sur Seine, France.
Christine A BricaultSanofi Vaccines, Sanofi, Cambridge, MA, United States.
Matías F Gutiérrez-GonzálezRagon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard, Cambridge, MA, United States.
Matheus Oliveira de SouzaDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, United States.
Joshua M DiNapoliSanofi Vaccines, Sanofi, Cambridge, MA, United States.
Emmanuelle VigneLarge Molecule Research, Sanofi, Vitry sur Seine, France.
Melody A ShahsavarianLarge Molecule Research, Sanofi, Vitry sur Seine, France.
Brandon J DeKoskyDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, United States.
Sanofi (France) · FRSanofi (United States) · USUniversity of Kansas · USRagon Institute of MGH, MIT and Harvard · USSanofi (Belgium) · BEMassachusetts Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular characterization of antibody immunity and human antibody discovery is mainly carried out using peripheral memory B cells, and occasionally plasmablasts, that express B cell receptors (BCRs) on their cell surface. Despite the importance of plasma cells (PCs) as the dominant source of circulating antibodies in serum, PCs are rarely utilized because they do not express surface BCRs and cannot be analyzed using antigen-based fluorescence-activated cell sorting. Here, we studied the antibodies encoded by the entire mature B cell populations, including PCs, and compared the antibody repertoires of bone marrow and spleen compartments elicited by immunization in a human immunoglobulin transgenic mouse strain. To circumvent prior technical limitations for analysis of plasma cells, we applied single-cell antibody heavy and light chain gene capture from the entire mature B cell repertoires followed by yeast display functional analysis using a cytokine as a model immunogen. We performed affinity-based sorting of antibody yeast display libraries and large-scale next-generation sequencing analyses to follow antibody lineage performance, with experimental validation of 76 monoclonal antibodies against the cytokine antigen that identified three antibodies with exquisite double-digit picomolar binding affinity. We observed that spleen B cell populations generated higher affinity antibodies compared to bone marrow PCs and that antigen-specific splenic B cells had higher average levels of somatic hypermutation. A degree of clonal overlap was also observed between bone marrow and spleen antibody repertoires, indicating common origins of certain clones across lymphoid compartments. These data demonstrate a new capacity to functionally analyze antigen-specific B cell populations of different lymphoid organs, including PCs, for high-affinity antibody discovery and detailed fundamental studies of antibody immunity.

Indexed as

Bone MarrowPlasma CellsAnimalsAntibodies, MonoclonalAntibody FormationCytokinesHumansMiceMice, TransgenicReceptors, Antigen, B-CellSaccharomyces cerevisiaeSpleenAntibodies, MonoclonalCytokinesReceptors, Antigen, B-Cellantibody discoveryantibody repertoire analysisB cellbone marrowcytokineplasma cellsspleenyeast surface display

Identifiers

PMID37346047
PMCPMC10280637
OpenAlexW4379518622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.